Abstract:AIM: To investigate the change of regional cerebral metabolism rate of glucose (rCMRglc) with the treatment of hydro-fluoxetine (prozac) and relationship with the changes of neuropsychology in patients with first-episode depression in the hope of providing some biological evidences for clinical diagnosis of depression. METHODS: Fourteen patients with first-episode depression from Shanghai Municipal Mental Healthy Center between January and September 2003 were selected. Assessment on clinical symptom and cognitive function linical diagnoses of depression with examination of positronemission tomography were done before treatment. After 12-weeks treatment with fluoxertine hydrochloride (mean dosage was 20 mg per day), the above examination and assessment were conducted again in 8 patients (the reducing score rate > 50% of Hamilton depression rating scale). In the same period, 11 healthy persons from body health center of Huashan Hospital were only detected with positronemission tomography and Hamilton depression rating scale. ① Semi-quantitative index of rCMRglc of different region of brain was observed in depression group and healthy control group. Semi-quantitative index of rCMRglc of different region of brain before and after treatment was observed in the depression group. ② Pearson correlation analysis was done on the changes of rCMRglc and the changes of every factor of Wechsler Memory Scale (WMS) after the treatment of fluoxertine hydrochloride in the depression group. ③ The changes of 1→100, 100→1, accumulation, pictures and recognition of the WMS were considered as dependent variable, and the changes of rCMRglc at the corresponding region as independent variable, and then performing the stepwise multiple regression analysis. RESULTS: ① The rCMRglc in superior frontal gyrus and cingulated gyrus at the right side in the depression group was (1.11±0.05)MBq/cc,(1.21±0.07)MBq/cc, respectively, which was lower significantly than that in the healthy control group (P < 0.05). ② The rCMRglc in right superior frontal gyrus in the effective depression group (1.17±0.08)MBq/cc was higher obviously than that before treatment (1.14±0.08) MBq/cc(P < 0.05). ③ After treatment, the changes of 1→100 of WMS in depression patients had positive correlation with the change of rCMRglc in right hippocampus. The change of 100→1 and understanding was negative to the change of rCMRglc in left superior frontal gyrus. The change of accumulation was positive to the change of rCMRglc in left superior frontal gyrus. The change of pictures and tactile sensation was positive to the change of rCMRglc in left middle frontal gyrus. The change of recognition was negative to the change of rCMRglc in left inferior frontal gyrus and is negative to the change of rCMRglc in right inferior frontal gyrus and right cingulated gyrus. The change of association was positive to the change of rCMRglc in left cingulated gyrus. The change of recitation was positive to the change of rCMRglc in right occipital lobe (P < 0.05 or P < 0.01), and all was enrolled in regression equations, and the coefficient of product-moment ranged from 0.723-0.913. CONCLUSION: The fluoxertine hydrochloride can effectively enhance the rCMRglc in superior frontal gyrus of first-episode depression patients. The amelioration of memory ability is related to the alteration of the rCMRglc in depression patients.

Characteristics of regional cerebral metabolic rate of glucose in association with the neuropsychological changes after the treatment of first-episode depression

Correlation of neurochemical metabolism with memory function in young adult patients with first-episode depression studied with proton magnetic resonance spectroscopy]

A 1H Magnetic Resonance Spectroscopy Imaging Study on Prefrontal and Hippocampus in Patients with Depression

565 – Abnormality of White Matter Structure and Resting State Brain Function in First-Episode, Treatment-Naive Patients with Major Depressive Disorder

The cognitive function in first-episode depression before and after therapy

[Repetitive Transcranial Magnetic Stimulation Combined with Antidepressant Medication in Treatment of First-Episode Patients with Major Depression].

Effect analysis of repeated transcranial magnetic stimulation combined with fluoxetine in the treatment of first-episode adolescent depression

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Altered Fractional Amplitude of Low Frequency Fluctuation Associated with Cognitive Dysfunction in First-Episode Drug-Naïve Major Depressive Disorder Patients

Regional Cerebral Metabolism Alterations Affect Resting-State Functional Connectivity in Major Depressive Disorder.

The characteristics of sympathetic skin response in patients with depression

Clinical serum metabolomics study on fluoxetine hydrochloride for depression

The effectiveness of vortioxetine on neurobiochemical metabolites and cognitive of major depressive disorders patients: A 8-week follow-up study

Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression

Amplitude of Low Frequency Fluctuation in First-onset Major Depressive Disorder by Antidepressant Treatment Investigated with Resting-state Functional MRI

Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder

Changes in white matter and the effects of fluoxetine on such changes in the CUS rat model of depression

Short-term Effects of Escitalopram on Regional Brain Function in First-Episode Drug-Naive Patients with Major Depressive Disorder Assessed by Resting-State Functional Magnetic Resonance Imaging

Study regional homogeneity and low frequency amplitude of brain resting state functional magnetic resonance imaging in patients with depression

Amplitude of low frequency fluctuation in first-episode depression and its relationship with the separate symptom clusters: a resting-state fMRI study